These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9270056)

  • 41. Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo.
    Ch'ng JL; Mulligan RC; Schimmel P; Holmes EW
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10006-10. PubMed ID: 2481308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.
    Kim DW; Yeo SI; Ryu HJ; Kim JE; Song HK; Kwon OS; Choi SY; Kang TC
    BMC Neurosci; 2010 Oct; 11():141. PubMed ID: 20979657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.
    Sajdel-Sulkowska EM; Marotta CA
    Science; 1984 Aug; 225(4665):947-9. PubMed ID: 6206567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creatine kinase in human erythrocytes: A genetic anomaly reveals presence of soluble brain-type isoform.
    Kay L; Tokarska-Schlattner M; Quenot-Carrias B; Goudet B; Bugert P; Arnold H; Scheuerbrandt G; Schlattner U
    Blood Cells Mol Dis; 2017 May; 64():33-37. PubMed ID: 28364583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Morphological and biochemical features of cerebral beta-amyloidosis in long-livers].
    Kozyrev KM; Siatkin SP; Berezov TT
    Vestn Ross Akad Med Nauk; 2002; (7):3-9. PubMed ID: 12187538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.
    Moore P; White J; Christiansen V; Grammas P
    Neurosci Lett; 1998 Sep; 254(1):29-32. PubMed ID: 9780084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acrylamide does not cause apparent changes in genetic expression of creatine kinase in rat cerebellum.
    Wispriyono B; Matsuoka M; Igisu H
    J UOEH; 2004 Mar; 26(1):51-7. PubMed ID: 15038071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients.
    Aksenova MV; Burbaeva GS; Kandror KV; Kapkov DV; Stepanov AS
    FEBS Lett; 1991 Feb; 279(1):55-7. PubMed ID: 1995343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder.
    MacDonald ML; Naydenov A; Chu M; Matzilevich D; Konradi C
    Bipolar Disord; 2006 Jun; 8(3):255-64. PubMed ID: 16696827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD).
    Lukiw WJ; Handley P; Wong L; Crapper McLachlan DR
    Neurochem Res; 1992 Jun; 17(6):591-7. PubMed ID: 1603265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes in CK-isozyme and cathepsin D levels with strangulated obstruction of the small intestine].
    Sun JH; Gao H; Xu SH
    Zhonghua Wai Ke Za Zhi; 1985 Oct; 23(10):597-600, 637. PubMed ID: 3830627
    [No Abstract]   [Full Text] [Related]  

  • 52. Microglial reaction in Pick's disease.
    Paulus W; Bancher C; Jellinger K
    Neurosci Lett; 1993 Oct; 161(1):89-92. PubMed ID: 8255555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Activity of hydrolytic enzymes in so-called Alzheimer's change in neurofibrils].
    Rotin LIa
    Biull Eksp Biol Med; 1972 Oct; 73(10):110-3. PubMed ID: 4635298
    [No Abstract]   [Full Text] [Related]  

  • 54. [CK-linked immunoglobulin in neuromuscular disorders].
    Itagaki Y; Nishitani H
    Rinsho Shinkeigaku; 1984 May; 24(5):463-6. PubMed ID: 6478711
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytoplasmic creatine kinase in normal and pathological human kidney tissue.
    González Buitrago JM; Corrales JJ; Pastor I; Navajo JA; Montero JM; Miralles JM
    Eur Urol; 1987; 13(1-2):100-2. PubMed ID: 3582438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Activity of creatinine kinase and its isoenzymes in the cerebrospinal fluid and blood serum of patients with traumatic brain edema].
    Lutz W; Chmielewski H; Pawlak J; Jazdzewski B
    Pol Tyg Lek; 1980 Apr; 35(14):497-9. PubMed ID: 7402959
    [No Abstract]   [Full Text] [Related]  

  • 57. Case study. Pick's of Alzheimer's syndrome.
    Abercrombie AC
    Dist Nurs; 1968 Sep; 11(6):135-6. PubMed ID: 5188068
    [No Abstract]   [Full Text] [Related]  

  • 58. Creatine as a Therapeutic Target in Alzheimer's Disease.
    Smith AN; Morris JK; Carbuhn AF; Herda TJ; Keller JE; Sullivan DK; Taylor MK
    Curr Dev Nutr; 2023 Nov; 7(11):102011. PubMed ID: 37881206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Heads Up" for Creatine Supplementation and its Potential Applications for Brain Health and Function.
    Candow DG; Forbes SC; Ostojic SM; Prokopidis K; Stock MS; Harmon KK; Faulkner P
    Sports Med; 2023 Dec; 53(Suppl 1):49-65. PubMed ID: 37368234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice.
    Wang Y; Hong Y; Yan J; Brown B; Lin X; Zhang X; Shen N; Li M; Cai J; Gordon M; Morgan D; Zhou Q; Cao C
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.